STAR Pharmaceutical Limited provided group financial guidance for the half year ended 30 June 2019. The Group is expected to report an operating loss for first half of 2019. The significant drop in an operating loss was mainly attributed to lower sales and lower profit margins of drugs during the second quarter of 2019.